Investors have a number of instruments open to them as ways of protecting against inflation, but what are the most important questions when deciding which method to choose?
It has been a hectic year for investors, with the eurozone debacle driving core bond yields to record lows, while equity markets were buffeted by fears over China and the US.
Schroders is to change the name of its £74m Medical Discovery fund as it brings the fund in line with competitors.
Schroders has reported a fall in pre-tax profits for the year to September and warned of a slowdown in its institutional business, although its intermediary arm has offered a boost.
MAM Funds' Simon Callow has been adding risk back into his £190m CF Midas Balanced Growth fund over the last quarter as policymakers work to steer the eurozone into recovery mode.
More Western asset managers look set to follow in the footsteps of Schroders and Invesco by acquiring stakes in Indian fund management companies to take advantage of a growing interest in investments.